
News|Articles|November 1, 2012
Pipeline Preview
Recent FDA action (through October 2012) related to, Treprostinil diethanolamine extended release tablets, Lomitapide, Mipomersen sodium, Xilonix, Ponatinib, Trospium chloride extended-release capsules
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
PBM reform. It has finally happened
3
FDA issues draft guidance on MRD and complete response as primary endpoints for accelerated multiple myeloma drug approvals
4
TrumpRx launches; some experts question its long-term value
5

























